Ask AI
ProCE Banner Activity

HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies: Safety and Adverse Event Management – Slides 

Slideset

Slides from Zev A. Wainberg, MD; Alexandra Leary, MD, PhD; and Catherine Fahey, MD, PhD, exploring the safety and adverse event management for HER2-targeted antibody–drug conjugates across genitourinary, gastrointestinal, and gynecologic cancers. 

Released: September 03, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.